Investors

Date	Name	Title	Type	Shares Traded	Price Range
Sep 2, 2011	aberman michael s	Officer	Option Execute	4,166	24.00
Sep 6, 2011	aberman michael s	Officer	Option Execute	8,334	24.00
Dec 18, 2012	aberman michael s	Officer	Option Execute	1,200	24.00
Nov 29, 2012	aberman michael s	Officer	Option Execute	8,334	24.00
May 24, 2012	aberman michael s	Officer	Option Execute	500	24.00
Dec 28, 2009	roberts william	Officer	Automatic Sell	12,500	23.99
Aug 6, 2012	brown michael s	Director	Option Execute	3,000	23.84
Nov 14, 2012	brown michael s	Director	Option Execute	7,000	23.84
Oct 25, 2012	brown michael s	Director	Option Execute	2,000	23.84
Oct 26, 2012	brown michael s	Director	Option Execute	3,000	23.84
Oct 14, 2011	goldstein joseph l	Director	Option Execute	10,000	23.84
Sep 1, 2009	roberts william	Officer	Automatic Sell	14,166	23.49
Sep 19, 2008	kolinski stuart	Officer	Sell	9,992	23.40 - 23.69
Sep 29, 2008	schleifer leonard s	Officer	Disposition (Non Open Market)	44,273	23.28
Sep 29, 2008	stahl neil	Officer	Disposition (Non Open Market)	14,683	23.28
Aug 12, 2009	roberts william	Officer	Automatic Sell	6,666	22.99
Sep 22, 2008	roberts william	Officer	Sell	9,692	22.84
Oct 1, 2008	goldstein joseph l	Director	Sell	500	22.32
Dec 20, 2007	schleifer leonard s	Officer	Automatic Sell	22,207	22.28
Dec 21, 2009	mccorkle douglas s	Officer	Automatic Sell	2,456	22.00
Showing 321-340 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.